Hey folks, Scott Weingard here, and this is an M-Crit Wii. A few days ago, I released the M-Crit

episode, episode 411, on the Andromeda Shock 2 trial, an incredibly important trial in

sepsis resuscitation. And I promised that today there would be a discussion with the lead

investigators. And that's what you're going to hear now. And for

folks listening for free, you're going to hear the full episode in its entirety because it's really

important and this deserves to be foam. So I'm joined with Dr. Glenn Hernandez, who is a full

professor and intensivist at Pontifical Catholic University in Chile,

and he is the lead investigator for Andromeda Shock 2, as well as Indromeda Shock 2, as well as Indromeda

Shock 1, and one of his former fellows, now associate professor and intensivist also at the same

institution, Eduardo Catan.

And I think these folks have now clearly won in my mind as the two folks who I have not yet

gone to a bar with in the intensive care world that I would most like to sit around and have a

drink, because these two, in addition to being brilliant researchers

and intensivists, are also just people full of a happiness and life. You'll get that flavor

in the next 60 minutes. We go in intricate detail to all aspects of Intrometer Shock 2.

Even after reading this trial multiple times, I still

learned a ton in the course of this conversation. And I think you're really going to love it.

So without further ado, let's get right into this M-Crit-Wee. All right. First of all, congratulations

on the trial. It's an amazing publication. It had to be a ton of work, so well done, both of you.

It was like in Everest, because we built up a sort of informal academic research organization,

informal, supported by some universities, but without formal funding or grants.

Since this is audio, I just want to point out that is the voice you've just heard of

...